VIVARA S.A. (VIVA3) Main Indicators
Basic Data - VIVA3
| Company | VIVARA S.A. |
| Corporate Name | VIVARA PARTICIPAÇOES S.A |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Participação em outras sociedades. na qualidade de quotistas. ou acionistas; holding de instituições não-financeiras; e agente de propriedade intelectual. |
| Share | VIVA3 |
| Quote Date | 09/18/2024 |
| Share Type | ON |
| Last Closing | R$ 28.69 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 109.54 M |
| Last Statement | ITR - 06/30/2024 |
| Sector | Consumo Cíclico |
| Subsector | Tecidos. Vestuário e Calçados |
| Segment | Acessórios |
| Participation Indexes | IBOVESPA, IBRA, IBRX, ICON, IGC, IGCT, IGNM, INDX, ITAG, IVBX, SMLL |
| Updated 09/19/2024 | |
Relative Prices - VIVA3
| Price/Earnings | 14.50 |
| Price/SBV | 3.12 |
| Price/Net Sales | 2.90 |
| Price/CFO | 15.73 |
| Price/FCF | 22.34 |
| Price/Total Assets | 1.97 |
| Price/EBIT | 12.52 |
| Price/Working Capital | 4.74 |
| Price/NCAV | 42.84 |
| EV/EBIT | 12.44 |
| EV/EBITDA | 9.75 |
| EV/Net Sales | 2.88 |
| EV/CFO | 15.64 |
| EV/FCF | 22.21 |
| EV/Total Assets | 1.96 |
| Company Market Cap | R$ 6.78 B |
| Enterprise Value | R$ 6.74 B |
| Current Financial Statement Date | 06/30/2024 |
| Current Share Price | R$ 28.69 |
| Share Price Date | 09/18/2024 |
| Dividend Yield | 1.30% |
| Updated 09/19/2024 | |
Income Statement - VIVA3
| Net Revenue | R$ 2.34 B |
| Gross Result | R$ 1.61 B |
| EBIT | R$ 541.42 M |
| Depreciation and Amortization | - R$ 149.72 M |
| EBITDA | R$ 691.14 M |
| Net Profit | R$ 467.46 M |
| Net Profit/Share | R$ 1.98 |
| Updated 08/08/2024 | |
| Net Revenue | R$ 656.32 M |
| Gross Result | R$ 451.76 M |
| EBIT | R$ 223.90 M |
| Depreciation and Amortization | - R$ 40.92 M |
| EBITDA | R$ 264.82 M |
| Net Profit | R$ 210.96 M |
| Profit/Share | R$ 0.89 |
| Updated 08/08/2024 | |
Price and Volume Behavior - VIVA3
| Lowest Price 52 weeks | R$ 19.83 |
| Highest Price 52 weeks | R$ 35.03 |
| Variation 2024 | -14.28% |
| Variation 1 year | 6.98% |
| Variation 2 years(total) | 19.61% |
| Variation 2 years(yearly) | 9.33% |
| Variation 3 years(total) | -1.58% |
| Variation 3 years(yearly) | -0.53% |
| Variation 4 years(total) | 28.67% |
| Variation 4 years(yearly) | 6.50% |
| Variation 5 years(total) | - |
| Variation 5 years(yearly) | - |
| Average Daily Volume (3 months) | R$ 81.79 M |
| Updated 09/19/2024 | |
Returns and Margins - VIVA3
| Return on Initial Tangible Capital | 15.39% |
| Return on Initial Invested Capital | 18.37% |
| Pre-Tax Return on Initial Tangible Capital | 23.31% |
| Pre-Tax Return on Initial Invested Capital | 27.83% |
| Return on Initial Shareholder´s Equity | 25.92% |
| Return on Initial Asset | 15.73% |
| Gross Margin | 68.83% |
| Net Margin | 20.01% |
| EBIT Margin | 23.17% |
| EBITDA Margin | 29.58% |
| Initial Asset Turnover | 0.79 |
| Financial Leverage | 1.58 |
| Liabilities/Net Worth | 0.58 |
| Net Debt/EBITDA | -0.06 |
| Updated 08/08/2024 | |
Balance Sheet - VIVA3
| Cash and Cash Equivalents | R$ 274.12 M |
| Total Assets | R$ 3.44 B |
| Short-Term Debt | R$ 126.08 M |
| Long-Term Debt | R$ 107.56 M |
| Gross Debt | R$ 233.64 M |
| Net Debt | - R$ 40.48 M |
| Shareholder´s Equity | R$ 2.17 B |
| Share Book Value | R$ 9.20 |
| Common Shares | 236,197,769 |
| Preferred Shares | 0 |
| Total | 236,197,769 |
| Common Shares in Treasury | 1,222,164 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 1,222,164 |
| Common Shares (Except Treasury) | 234,975,605 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 234,975,605 |
| Updated 08/08/2024 | |
Cash Flow - VIVA3
| Operating Cash Flow | R$ 430.80 M |
| Cash Flow from Investments | - R$ 78.53 M |
| Financing Cash Flow | - R$ 156.62 M |
| Increase (Reduction) in Cash and Equivalents | R$ 195.66 M |
| Updated 08/08/2024 | |
| Operating Cash Flow | R$ 125.68 M |
| Cash Flow from Investments | - R$ 15.70 M |
| Financing Cash Flow | - R$ 106.06 M |
| Increase (Reduction) in Cash and Equivalents | R$ 3.92 M |
| Updated 08/08/2024 | |
Experimental - VIVA3
| CAPEX 3 months | - R$ 25.13 M |
| Free Cash Flow 3 months | R$ 100.55 M |
| CAPEX 12 months | - R$ 127.48 M |
| Free Cash Flow 12 months | R$ 303.33 M |
| Updated 08/08/2024 | |